{
    "1695003621392368035": {
        "author_id": "194037150",
        "created_at": "2023-08-25T09:22:09.000Z",
        "edit_history_tweet_ids": [
            "1695003621392368035"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 19,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.6721,
                    "start": 8,
                    "type": "Organization"
                }
            ],
            "hashtags": [
                {
                    "end": 6,
                    "start": 0,
                    "tag": "PRESS"
                }
            ]
        },
        "id": "1695003621392368035",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 1,
            "impression_count": 6396,
            "like_count": 43,
            "quote_count": 3,
            "reply_count": 0,
            "retweet_count": 10
        },
        "text": "#PRESS: Novo Nordisk product shows large reductions in heart failurerelated symptoms and physical limitations in people with heart failure with preserved ejection fraction and obesity"
    }
}